An open 36-month study of lipid changes with growth hormone in adults: Lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency

European Journal of Endocrinology

Volumn 134, Issue 1, 1996, Pages 61-66

  Garry, P ^a   Collins, P ^b   Devlin, J G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HUMAN GROWTH HORMONE; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GROWTH HORMONE DEFICIENCY; HUMAN; LIPID METABOLISM; MALE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK;

EID: 0030028592     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340061     Document Type: Article

References (35)

1. Raben MS. Clmical use of human growth hormone. New Engl J Med 1962;266:82-6
2. Rosen T, Bengtsson B-A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;356:285-8
3. Shahi M, Beshyah SA, Hackett D, Sharp P, Johnston D, Foale R, Cardiac structure and function in growth hormone deficiency. Br Heart J 1991;66:58
4. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. Detection of premature atherosclerosis by high resolution ultrasonography in symptom free hypopituitary adults. Lancet 1992:340(8229):1188-92
5. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45-52
6. Salomon F, Cuneo RC, Hesp R, Sonksen PH, The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New Engl J Med 1989;321:1797-803
7. Edén S, Wiklund O, Oscarsson J, Rosen T, Bengtsson B-A. Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 1993;13:296-301
8. Russell-Jones DL, Weissberger AJ, Watts GF, Naoumova R, Myers J, Thompson GR, The effects of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Endocrinol Metab 1994:1 Suppl. Abstract 13
9. Olivecrona H, Ericsson S, Berglund L, Angelin B, Increased concentrations of Lipoprotein(a) in response to growth hormone treatment. Br Med J 1993;306:1726-7
10. Modigliani E, Kerchouni R, Uzzan B, Valensi P, Chanson P, Caron J, Modification of blood lipids and lipoproteins after human growth hormone treatment in adults with growth hormone deficiency: a preliminary report. Endocrinol Metab 1994: Suppl A:31-5
11. O'Halloran DJ, Wieringa G, Tsatsoulis A, Shalet SM, Serum lipoprotein(a) levels increase after recombinant human growth hormone in adults with isolated growth hormone deficiency. J Endocrinol 1994:140 Suppl (Abstract P171)
12. Jacobs DR, Krieger DT, Charles RN. Late appearance of hyperlipaemia in hypopituitarism. Ann Int Med 1961:55:640-6
13. Summers VK, Hipkin LJ, Davis JC, Serum lipids in diseases of the pituitary. Metab 1967;12:1106-13
14. Friedman M, Byers SO, Elek SR, Pituitary growth hormone essential for regulation of serum cholesterol. Nature 1970;60: 648-57
15. Merimee TJ, Hollander W, Fineberg SE, Studies of hyperlipidemia in the hgh-deficient state. Metabolism 1972;21:1053-61
16. Merimee TJ, Pulkkinen A, Familial combined hyperlipoproteinemia: evidence for a role of growth hormone deficiency in effecting its manifestation. J Clin Invest 1980;65:829-35
17. Libber SM, Plotnick LP, Johanson AJ, Blizzard RM, Kviterovich PO, Migeon CJ. Long-term follow-up of hypopituitary adults treated with human growth hormone. Medicine 1990;69:46-55
18. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH, Growth hormone treatment improves serum lipids and apoproteins in adults with growth hormone deficiency. Metab Clin Exp 1993;42(11):1443-7
19. Rosen T, Eden S, Larsson G, Wilhelmsen L, Bengtsson B-A. Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol 1993;129:195-200.
20. Angelin B, Rudling M, Growth hormone and hepatic lipoprotein metabolism. Curr Opin Lipid 1994;5:160-5
21. De Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA. Serum lipid levels in growth hormone deficient men. Metab Clin Exp 1994;43:199-203
22. Wuster C. Slenczka E, Ziegler R, Erhohte pravalenz von osteoporose und arteriosklerose bei konventionell substituierter hypophysen-vorderlappeninsuffizienz: bedarf einer zusatzlichen wachstum-shormonsubstitution? Klin Wochenschr 1991;69:769-73
23. Beshyah SA, Henderson A, Richmond W, Johnston D, The effect of long-term growth hormone replacement in hypopituitary adults on plasma lipids, lipoprotems and apoproteins. J Endocrinol 1994:140 Suppl (Abstract P165)
24. Beauville M, Harant I, Crampes F, Riviere D, Tauber JP. Garrigues M, Effect of long-term rhGH administration in GH-deficient adults on the response of fat cells to epinephrine. Am J Phys 1992;263: 5467-72
25. Angelin B, Rudling M, Olivecrona H, Ericsson S, Effects of growth hormone on low density lipoprotein metabolism. Acta Paediatr 1992 Suppl 583:67-8
26. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler R, Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Int Med 1993;234(31):249-55
27. De Boer H, Blok GJ, Voerman HJ, Phillips M, Schouten JA, Serum lipid levels in growth hormone-deficient men, Metab Clin Exp 1994;43(2):199-203
28. Oscarsson J, Wiklund O, Jakobsson KE Petruson B, Bengtsson BA, Serum lipoproteins in acromegaly before and 6-15 months after transsphenoidal adenomectomy. Clin Endocrinol 1994;41(5): 603-8
29. Wallach J. Interpretation of diagnostic tests (fifth ed.) 1992: Little. Brown, pp.14-15
30. 1 lipoprotein in patients with coronary heart disease. Clin Gen 1974;6:230-5
31. Rosengren A, Wilhelmsen L, Eriksen E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective study in a general population of middle-aged men. Br Med J 1990;301: 1248-51
32. Wald NJ, Law M, Watt HC, Wu T, Bailey A, Johnson AM, et al. Apolipoproteins and ischaemic heart disease: implications for screening. Lancet 1994;343(8889):75-9
33. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA 1993;270:2195-9
34. Russell-Jones DL, Cuneo RC, Salomon F, Hesp R, Sonksen P, Weissberger AJ. Changes in body composition in adult growth-hormone deficient patients withdrawn from long-term treatment: comparison of total body potassium and bioelectrical impedance measurements. J Endocrinol 1992;132 Suppl: 232
35. Jorgensen JO, Thuesen L, Muller J, Ovesen P, Skakkebaek NE, Christiansen JS, Three years of growth hormone treatment in growth hormone deficient adults: near-normalization of body composition and physical performance. Eur J Endocrinol 1994;130(3):224-8